In vivo effects of rosiglitazone in a human neuroblastoma xenograft

BACKGROUND: Neuroblastoma (NB) is the most common extra-cranial solid tumour in infants. Unfortunately, most children present with advanced disease and have a poor prognosis. There is in vitro evidence that the peroxisome proliferator-activated receptor γ (PPARγ) might be a target for pharmacologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Cellai, I, Petrangolini, G, Tortoreto, M, Pratesi, G, Luciani, P, Deledda, C, Benvenuti, S, Ricordati, C, Gelmini, S, Ceni, E, Galli, A, Balzi, M, Faraoni, P, Serio, M, Peri, A
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837558/
https://www.ncbi.nlm.nih.gov/pubmed/20068562
http://dx.doi.org/10.1038/sj.bjc.6605506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837558/
https://www.ncbi.nlm.nih.gov/pubmed/20068562
http://dx.doi.org/10.1038/sj.bjc.6605506

Ejemplares similares